Unilife Corp. has signed a long-term contract with Sanofi to supply Unifill Finesse, a customized device from its Unifill platform of prefilled syringes with automatic needle retraction for use with Lovenox and Clexane. The contract period can extend to 2024.   Unilife has granted Sanofi the exclusive use of the Unifill Finesse with anti-thrombotic drugs during the contract period. Sanofi will maintain exclusivity, subject to purchasing a minimum of 150 million units of the Unifill Finesse or ot...